Exponent (NASDAQ:EXPO - Get Free Report) is anticipated to release its Q1 2025 earnings data after the market closes on Thursday, May 1st. Analysts expect the company to announce earnings of $0.48 per share and revenue of $134.63 million for the quarter.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period in the prior year, the firm posted $0.41 earnings per share. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Exponent Price Performance
EXPO stock opened at $79.98 on Thursday. Exponent has a 1 year low of $73.83 and a 1 year high of $115.75. The company has a market cap of $4.06 billion, a P/E ratio of 37.73 and a beta of 0.84. The stock's fifty day moving average price is $81.72 and its 200-day moving average price is $91.49.
Insiders Place Their Bets
In other news, VP Richard Reiss sold 1,736 shares of the stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the transaction, the vice president now owns 1,800 shares in the company, valued at $154,674. This represents a 49.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 2.10% of the company's stock.
About Exponent
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
